Brie Carter

Mechanics Bancorp (NASDAQ:MCHB) saw its first-quarter earnings fall significantly compared to the previous period, reflecting a contraction in its loan portfolio and a strategic build-up in credit loss reserves.

Mesoblast (NASDAQ:MESO) reported robust financial results for the first quarter of 2026, driven by the successful commercial trajectory of Ryoncil (remestemcel-L).

The U.S. Department of Labor has launched a new online portal to help workers and employers develop artificial intelligence skills and expand apprenticeship programmes.

Evotec (NASDAQ:EVO) has secured two new grants from the Bill & Melinda Gates Foundation totaling $9.9 million, aimed at accelerating the discovery and development of next-generation treatments for tuberculosis (TB).

Celsius founder Alex Mashinsky has agreed to a settlement with the Federal Trade Commission requiring a $10 million payment and imposing a permanent ban on promoting asset-related products.

KuCoin’s European arm has appointed a new Anti-Money Laundering chief and expanded its compliance team following a regulatory ban in Austria.

Crypto-related stocks slid sharply as Robinhood led declines following a weak earnings report and escalating geopolitical tensions between the US and Iran.

Stable Sea has integrated WisdomTree’s tokenised US Treasury money market fund into its platform, enabling businesses to earn yield on idle cash through blockchain-based infrastructure.

The Federal Reserve is currently facing its most significant internal upheaval in over three decades.

In a historic 8-4 vote, the central bank opted to maintain interest rates, marking the most fractured decision since 1992.

Mesoblast (NASDAQ:MESO) announced a significant clinical milestone on Wednesday, April 29, 2026, confirming that its pivotal Phase 3 trial (MSB-DR004) for rexlemestrocel-L has successfully met its patient recruitment target.